lupin sees licensing income of rs 210 cr in q3
Published 5 years ago • 1.2K plays • Length 25:46Download video MP4
Download video MP3
Similar videos
-
9:38
we should see $200-210 million of quarterly sales in the u.s.: lupin | cnbc tv18
-
3:00
lupin mgmt on weak q3 number | co q3 nos fall to rs 221.7 cr. | cnbc tv18
-
11:38
rising gold prices have enabled customers to borrow more from the same collateral gold: muthoot fin
-
11:55
hdfc q3 profit falls 14% to rs 2,114 cr sequentially, provision decline sharply
-
18:07
'india has contributed 20% of global chip design for decades': jacobs solutions global ceo
-
7:09
all you need to know about real estate trends | rate cuts to spur home loan dreams? | centuryply
-
3:29
auto industry 'past the point of no return' on the path to full electrification, advisory firm says
-
5:41
lupin posts net profit of ₹130 crore in q2: deven choksey's take on pharma stocks | cnbc-tv18
-
3:05
dipen mehta on lupin: exit the stock on rallies & get into consumption oriented stocks
-
1:22
lupin q1fy25 results beat estimates, co sees strong growth in india & us businesses | cnbc tv18
-
8:32
very solid performance across in-licensing business & new product launches in the us: lupin
-
6:00
cipla, lupin q3 results today: key things to watch out for
-
11:05
cnbc-tv18 live | lupin ltd reports q4 earnings | earnings central
-
1:00
lupin aspires to reach $5 billion in revenues
-
6:36
15 feb 2023: rajesh bhatia group cfo uflex, in an interview with cnbc tv18 on q3 fy23 results
-
3:19
lupin q3 net profit dips 65% to rs 222 crore
-
1:26
stock watch: lupin zooms 4% after receiving gspiriva approval from usfda
-
10:06
hdfc securities)cnbc tv18 on lupin earnings
-
4:41
lupin & i’rom enter into licensing agreement for denosumab biosimilar in japan | trading hour
-
2:00
what should you expect from lupin this q1?
-
0:55
indian gaming giant worth 5000 crore rs 😮😮 #nazara #gaming